BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 12870231)

  • 1. [Digoxin plasma levels in four different prescription schedules of common use in clinical practice].
    Reinbach R; Villa L; Giraudo P; Venegas R; Fernández P
    Rev Med Chil; 2003 Apr; 131(4):373-80. PubMed ID: 12870231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Do we use digitalis properly in the management of elderly patients suffering from the signs of chronic heart failure?].
    Erdei F; Vendrey R; Dani G; Kovács E; Márk L; Katona A
    Orv Hetil; 2006 Oct; 147(41):1993-6. PubMed ID: 17120690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Digoxin: continuous or discontinuous treatment?].
    Gnocchi CA; Mazzocchi O; Yaryour C; Khoury MC; Noel ME; Torn A; Risso JA
    Medicina (B Aires); 1998; 58(3):271-6. PubMed ID: 9713095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biochemical evaluation of digoxin dosage in patients with heart failure].
    Jabłecka A
    Wiad Lek; 1994 Aug; 47(15-16):579-82. PubMed ID: 7716953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A method of determining the dose of digoxin for heart failure in the modern era.
    Bauman JL; DiDomenico RJ; Viana M; Fitch M
    Arch Intern Med; 2006 Dec 11-25; 166(22):2539-45. PubMed ID: 17159022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of MDRD equation to detect occult renal failure and reduce the risk of digitalis overdose].
    Cepeda Piorno J; Pobes Martínez de Salinas A; González García ME; Fernández Rodríguez E
    Nefrologia; 2009; 29(2):150-5. PubMed ID: 19396321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digoxin may reduce the mortality rates in patients with congestive heart failure.
    Wang L; Song S
    Med Hypotheses; 2005; 64(1):124-6. PubMed ID: 15533628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A possible interaction of potential clinical interest between digoxin and acarbose.
    Serrano JS; Jiménez CM; Serrano MI; Balboa B
    Clin Pharmacol Ther; 1996 Nov; 60(5):589-92. PubMed ID: 8941033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum digoxin concentration: dependence on body weight and age].
    Kaufmann G; Neumann P
    Schweiz Med Wochenschr; 1977 Nov; 107(47):1695-9. PubMed ID: 929130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the accuracy of a computerized decision support system for digoxin dosing in primary care: an observational study.
    Kroese WL; Avery AJ; Savelyich BS; Brown NS; Schers H; Howard R; Hippisley-Cox J; Horsfield P
    J Clin Pharm Ther; 2005 Jun; 30(3):279-83. PubMed ID: 15896246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preoperative digitalization. Measurement of digoxin plasma levels (author's transl)].
    Geiger HJ; Rietbrock N
    Anaesthesist; 1976 Sep; 25(9):405-17. PubMed ID: 970596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of pengitoxin and its therapeutic efficacy in congestive heart failure.
    Haustein KO; Wesser M
    Int J Clin Pharmacol Ther Toxicol; 1988 Jan; 26(1):8-15. PubMed ID: 3403092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The level of plasma neuroendocrine activity and the concentration of digoxin in the serum of patients with mild chronic heart failure.
    Jablecka A; Chmara E; Korzeniowska K
    Int J Clin Pharmacol Res; 1998; 18(4):171-8. PubMed ID: 10052027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muzolimine therapy in patients with congestive heart failure in comparison with furosemide pretreatment. Effect on digoxin plasma concentration.
    Kahles H; Ertl G; Riegger G; Liebau G; Kochsiek K
    Z Kardiol; 1985; 74 Suppl 2():24-6. PubMed ID: 4002799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Routine serum digoxin determination on hospital admission (author's transl)].
    Kühn P; Hohenwallner W; Wimmer E; Sommer R
    Wien Klin Wochenschr; 1980 May; 92(10):356-60. PubMed ID: 7395223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical study on digoxin tablets with high bioavailability (author's transl)].
    Flasch CI; Heinz N
    Arzneimittelforschung; 1979; 29(6):961-4. PubMed ID: 582792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of target concentration intervention strategy with conventional dosing of digoxin.
    Rajendran SD; Rao YM; Thanikachalam S; Muralidharan TR; Anbalagan M
    Indian Heart J; 2005; 57(3):265-7. PubMed ID: 16196188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of digitalis: a prospective study on the posology of digoxin with weekly interruption].
    Soto Pedre E; Castro Beirás A; Cuña Estévez B
    Rev Esp Cardiol; 1990; 43(7):438-43. PubMed ID: 2093956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Blood digoxin and treatment of heart failure in aged patients].
    Jouannot P; Lavabre J; Thomas M; Hatt PY
    Arch Mal Coeur Vaiss; 1976 Oct; 69(10):1013-21. PubMed ID: 827994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of exenatide on the steady-state pharmacokinetics of digoxin.
    Kothare PA; Soon DK; Linnebjerg H; Park S; Chan C; Yeo A; Lim M; Mace KF; Wise SD
    J Clin Pharmacol; 2005 Sep; 45(9):1032-7. PubMed ID: 16100297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.